Cargando…

‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities

The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost an...

Descripción completa

Detalles Bibliográficos
Autores principales: Moosavinasab, Soheil, Patterson, Jeremy, Strouse, Robert, Rastegar-Mojarad, Majid, Regan, Kelly, Payne, Philip R. O., Huang, Yungui, Lin, Simon M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869799/
https://www.ncbi.nlm.nih.gov/pubmed/27189611
http://dx.doi.org/10.1093/database/baw083
_version_ 1782432377369264128
author Moosavinasab, Soheil
Patterson, Jeremy
Strouse, Robert
Rastegar-Mojarad, Majid
Regan, Kelly
Payne, Philip R. O.
Huang, Yungui
Lin, Simon M.
author_facet Moosavinasab, Soheil
Patterson, Jeremy
Strouse, Robert
Rastegar-Mojarad, Majid
Regan, Kelly
Payne, Philip R. O.
Huang, Yungui
Lin, Simon M.
author_sort Moosavinasab, Soheil
collection PubMed
description The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost and fast FDA approval. Here, we introduce ‘RE:fine Drugs’, a freely available interactive website for integrated search and discovery of drug repurposing candidates from GWAS and PheWAS repurposing datasets constructed using previously reported methods in Nature Biotechnology. ‘RE:fine Drugs’ demonstrates the possibilities to identify and prioritize novelty of candidates for drug repurposing based on the theory of transitive Drug–Gene–Disease triads. This public website provides a starting point for research, industry, clinical and regulatory communities to accelerate the investigation and validation of new therapeutic use of old drugs. Database URL: http://drug-repurposing.nationwidechildrens.org
format Online
Article
Text
id pubmed-4869799
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-48697992016-05-26 ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities Moosavinasab, Soheil Patterson, Jeremy Strouse, Robert Rastegar-Mojarad, Majid Regan, Kelly Payne, Philip R. O. Huang, Yungui Lin, Simon M. Database (Oxford) Database Tool The process of discovering new drugs has been extremely costly and slow in the last decades despite enormous investment in pharmaceutical research. Drug repurposing enables researchers to speed up the process of discovering other conditions that existing drugs can effectively treat, with low cost and fast FDA approval. Here, we introduce ‘RE:fine Drugs’, a freely available interactive website for integrated search and discovery of drug repurposing candidates from GWAS and PheWAS repurposing datasets constructed using previously reported methods in Nature Biotechnology. ‘RE:fine Drugs’ demonstrates the possibilities to identify and prioritize novelty of candidates for drug repurposing based on the theory of transitive Drug–Gene–Disease triads. This public website provides a starting point for research, industry, clinical and regulatory communities to accelerate the investigation and validation of new therapeutic use of old drugs. Database URL: http://drug-repurposing.nationwidechildrens.org Oxford University Press 2016-05-17 /pmc/articles/PMC4869799/ /pubmed/27189611 http://dx.doi.org/10.1093/database/baw083 Text en © The Author(s) 2016. Published by Oxford University Press. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Database Tool
Moosavinasab, Soheil
Patterson, Jeremy
Strouse, Robert
Rastegar-Mojarad, Majid
Regan, Kelly
Payne, Philip R. O.
Huang, Yungui
Lin, Simon M.
‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
title ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
title_full ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
title_fullStr ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
title_full_unstemmed ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
title_short ‘RE:fine drugs’: an interactive dashboard to access drug repurposing opportunities
title_sort ‘re:fine drugs’: an interactive dashboard to access drug repurposing opportunities
topic Database Tool
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869799/
https://www.ncbi.nlm.nih.gov/pubmed/27189611
http://dx.doi.org/10.1093/database/baw083
work_keys_str_mv AT moosavinasabsoheil refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT pattersonjeremy refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT strouserobert refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT rastegarmojaradmajid refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT regankelly refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT paynephilipro refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT huangyungui refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities
AT linsimonm refinedrugsaninteractivedashboardtoaccessdrugrepurposingopportunities